Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.50
-0.05 (-0.11%)
Apr 24, 2025, 1:30 PM CST

Orient EuroPharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3,8604,1813,3743,1403,1534,173
Upgrade
Market Cap Growth
23.91%23.91%7.46%-0.41%-24.43%-13.49%
Upgrade
Enterprise Value
7,1408,2677,2746,4275,2925,012
Upgrade
Last Close Price
44.5048.2038.1235.4834.7444.26
Upgrade
PE Ratio
--23.44-26.2420.94
Upgrade
PS Ratio
0.880.950.740.660.660.78
Upgrade
PB Ratio
0.660.720.810.910.911.07
Upgrade
P/TBV Ratio
0.750.820.971.091.101.34
Upgrade
P/FCF Ratio
-----11.10
Upgrade
P/OCF Ratio
--52.18-40.616.86
Upgrade
EV/Sales Ratio
1.631.881.581.361.110.93
Upgrade
EV/EBITDA Ratio
41.3553.8730.85913.2387.7218.01
Upgrade
EV/EBIT Ratio
--103.01--42.71
Upgrade
EV/FCF Ratio
-32.43----13.34
Upgrade
Debt / Equity Ratio
0.730.731.161.461.220.62
Upgrade
Debt / EBITDA Ratio
21.1521.1516.88112.2144.257.65
Upgrade
Debt / FCF Ratio
-----6.40
Upgrade
Asset Turnover
0.390.390.430.480.540.67
Upgrade
Inventory Turnover
2.102.102.002.262.152.10
Upgrade
Quick Ratio
0.750.750.730.690.821.18
Upgrade
Current Ratio
1.201.201.141.101.221.78
Upgrade
Return on Equity (ROE)
-4.63%-4.63%4.45%-8.57%2.02%2.77%
Upgrade
Return on Assets (ROA)
-0.04%-0.04%0.42%-0.94%-0.68%0.92%
Upgrade
Return on Capital (ROIC)
-0.04%-0.04%0.51%-1.16%-0.85%1.19%
Upgrade
Return on Capital Employed (ROCE)
--1.00%--2.00%
Upgrade
Earnings Yield
-7.36%-6.79%4.27%-9.90%3.81%4.78%
Upgrade
FCF Yield
-5.70%-5.27%-1.03%-27.32%-47.10%9.01%
Upgrade
Dividend Yield
2.29%2.08%2.62%-2.45%3.39%
Upgrade
Payout Ratio
----108.28%78.35%
Upgrade
Buyback Yield / Dilution
0.23%0.23%-0.23%0.24%0.21%-0.07%
Upgrade
Total Shareholder Return
2.52%2.30%2.39%0.24%2.66%3.32%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.